Austin, TX (Vocus/PRWEB) March 22, 2011
The CDISC Interchange Europe will be held in Brussels, Belgium on 13-14 April 2011. Dr. Pierre-Yves Lastic, Chair of the European CDISC Coordinating Committee (E3C), will open the Interchange and highlight speakers from the European Commission (EC) and the Innovative Medicines Initiative (IMI). The Keynote presentation will be delivered by Dr. Ilias Iakovidis, who is Deputy Head of the “Information and Communications Technologies (ICT) for Health” Unit for the Digital Information Society (DG INFSO) and he leads the ICT for Inclusion Unit responsible for the inclusion and ICT for Ageing Research. In 2001, Dr. Iakovidis was elected fellow of the American College of Medical Informatics for his contributions to that field.
Ann Martin, Principal Scientific Manager and Statistician, is responsible for the Knowledge Management aspects of the research collaborations of the Innovative Medicines Initiative (IMI), a public-private partnership between The European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Ann is responsible for developing and implementing the IMI Knowledge Management Strategy, including the data processing infrastructure, document management and e-collaboration platforms. She will speak in the Closing Plenary session of the CDISC Interchange. Ms. Martin commented, "a major bottleneck in drug development is the effective sharing of data for translational research. The key to address the hurdle lies in the consensus around standards for research, clinical and healthcare data. Only then will we be able to gain the insights for faster and more efficient discovery and development of safe and effective medicines for patients".
Dr. Pierre-Yves Lastic, Chairman of the European CDISC Coordinating Committee (E3C), will reminisce on 10 years of CDISC in Europe. Dr. Lastic served as a Director on the CDISC Board of Directors for the two-term (6 year) limit, and he continues as an ex-officio member in his role as leader of the E3C. “I am very pleased with the program that the E3C has organized for its European CDISC Interchange this year”, states Dr. Lastic, “In addition to excellent keynotes and plenary speakers, there are numerous presentation slated to demonstrate the value of the CDISC standards in improving the medical research process to bring new therapies to patients sooner”.
On 11, 12 and 15 April, there will be CDISC authorized training courses, including ‘A Global Approach to Accelerating Medical Research’ and courses on the suite of CDISC standards that facilitate clinical research studies from protocol through analysis and reporting. The evening networking event will be held at the Brussels Comic Strip Center. The CDISC Board of Directors will hold its Annual Meeting on 11-12 April in Brussels just prior to the Interchange.
CDISC would like to thank Oracle Health Sciences for their sponsorship of all the CDISC Interchange events in 2011 and our Patron Absolute Clinical Data Systems in China. Future CDISC Interchanges are scheduled in Japan on 12 – 15 July 2011 and in North America (Baltimore) on 10 – 14 October 2011.
For more information or to register, please see: http://www.cdisc.org/interchange .
CDISC is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission and archive of clinical research data and metadata. The CDISC mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website. Additional information on CDISC can be found on the CDISC website at http://www.cdisc.org.
The CDISC Vision: Informing patient care and safety through higher quality medical research
# # #